InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-09-25 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-07-22 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $1.52B+11.8% | $1.36B+7.9% | $1.26B+9.2% | $1.15B+7.1% | $1.07B |
| Cost of sales | $777.6M+9.0% | $713.2M+5.9% | $673.5M+6.6% | $631.9M+7.2% | $589.4M |
| Gross profit | $738.3M+14.8% | $643.3M+10.2% | $583.9M+12.5% | $519.1M+7.0% | $485.3M |
| Selling, general and administrative | $455.2M+13.9% | $399.7M+7.0% | $373.7M+9.1% | $342.5M+2.0% | $335.7M |
| Research and development | $97.4M+11.3% | $87.5M+5.7% | $82.7M+9.6% | $75.5M+6.0% | $71.2M |
| Impairment charges | $270K | — | — | — | $4.3M |
| Contingent consideration expense | $984K+122.1% | $443K-74.0% | $1.7M-63.0% | $4.6M+45.9% | $3.2M |
| Acquired in-process research and development | $1.6M | — | — | — | — |
| Total operating expenses | $553.5M+13.5% | $487.6M+6.0% | $459.9M+6.6% | $431.5M+1.7% | $424.4M |
| Income from operations | $184.7M+18.6% | $155.7M+25.6% | $123.9M+41.5% | $87.6M+43.7% | $60.9M |
| Interest income | $15.1M-42.5% | $26.2M+968.0% | $2.5M+459.5% | $439K-42.9% | $769K |
| Interest expense | -$26.5M+15.2% | -$31.2M-101.3% | -$15.5M-144.7% | -$6.3M-20.5% | -$5.3M |
| Other (expense) income - net | -$2.4M-236.4% | -$711K-159.3% | $1.2M | — | — |
| Total other expense - net | -$13.8M-141.8% | -$5.7M+51.9% | -$11.9M-140.3% | -$4.9M+29.5% | -$7.0M |
| Income before income taxes | $170.9M+14.0% | $150.0M+33.8% | $112.1M+35.7% | $82.6M+53.3% | $53.9M |
| Income tax expense | $42.4M+43.2% | $29.6M+67.6% | $17.7M+117.9% | $8.1M+48.5% | $5.5M |
| Net income | $128.5M+6.8% | $120.4M+27.5% | $94.4M+26.7% | $74.5M+53.8% | $48.5M |
| Basic (in dollars per share) | $2K+4.8% | $2K+26.2% | $2K+25.2% | $1K+52.3% | $860 |
| Diluted (in dollars per share) | $2K+4.9% | $2K+25.3% | $2K+25.6% | $1K+53.6% | $840 |
| Basic (in shares) | $59.2M+1.6% | $58.2M+1.1% | $57.6M+1.4% | $56.8M+1.2% | $56.1M |
| Diluted (in shares) | $60.5M+1.8% | $59.4M+1.7% | $58.4M+1.2% | $57.7M+0.5% | $57.4M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
MMSI Q1 Deep Dive: Oncology Expansion and Platform Realignment Drive Outlook
Merit Medical Systems: Creating More Growth Engines (Rating Upgrade)
Merit Medical Q1 Earnings & Revenues Beat Estimates, Sales View Up
Merit Medical (MMSI) Q1 2026 Earnings Transcript